The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 07, 2026

Filed:

Sep. 27, 2020
Applicant:

China Medical University, Taichung, TW;

Inventors:

Woei-Cherng Shyu, Taichung, TW;

Chien-Lin Chen, Taichung, TW;

Yi-Hui Lee, Taichung, TW;

Long-Bin Jeng, Taichung, TW;

Chang-Hai Tsai, Taichung, TW;

Assignee:

CHINA MEDICAL UNIVERSITY, Taichung, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0775 (2010.01); A61K 9/00 (2006.01); A61K 35/28 (2015.01); A61P 9/10 (2006.01); C12N 15/86 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0663 (2013.01); A61K 9/0019 (2013.01); A61K 35/28 (2013.01); A61P 9/10 (2018.01); C12N 15/86 (2013.01); C12N 2740/16043 (2013.01);
Abstract

Accordingly, the present disclosure provides a population of genetically engineered mesenchymal stem cells (MSCs), comprising an expression vector comprising an Akt or HGF gene and a PD-L1 gene. Also provided is a method for synergistically increasing survival status and immunomodulatory ability of an MSC or enhancing proliferation of an MSC, comprising transfecting an MSC with an Akt or HGF gene and a PD-L1 gene and a method for preventing, ameliorating and/or treating an ischemia condition, enhancing neuroregeneration or reducing neuronal death, comprising administering an effective amount of a population of genetically engineered MSCs of the present disclosure to a subject in need thereof.


Find Patent Forward Citations

Loading…